Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the ...

A consultant working for the EPA identified numerous scenarios in which the public — particularly road-construction workers — ...

Craig Evan Royce, author of Uranium Seekers, presented on the history of Temple Mountain on Oct. 30 during the Carbon County ...

The Columbus State University production of "These Shining Lives" opens Nov. 8 at CSU's Riverside Theatre Complex in downtown Columbus, Georgia. Written by Melanie Marnich, the play is based on the ...

Shorter days, longer nights…we’re moving into the best months of the year to curl up with a good book, a hot cup of tea (or ...

Columbus North Drama is preparing for its fall production on Halloween night, but anything spooky happening outside the walls ...

Scientists and clinicians at the University of Leeds exploring new radiotherapy treatments and technologies have been given a ...

Following a pair of lighthearted comedies, Buena Vista High School’s Trident Theatre Company is taking on a more somber, ...

Catch Saratoga High School’s fall play, “Radium Girls,” at the school’s McAfee Center this month. The play runs Nov. 8-16 and ...

RAD-18-002 is a Phase 1/2a open-label study designed to select the clinical dose, and evaluate the safety, tolerability, and signal of efficacy of intraperitoneally administered Radspherin® in ...